Everything tagged "medical diagnostics and research" across the TickerSpark archives.
Agilent Technologies, Inc. (A) gains after a stronger-than-expected quarter, with EPS and revenue both topping estimates. Our deep-dive looks beyond the headline beat at end-market momentum, guidance lift, tariff offsets, and the demand signals behind the after-hours move.
Agilent Technologies, Inc. (A) gains after reporting earnings beats, lifting shares 4.0% as investors react to stronger-than-expected quarterly results.
IDEXX Laboratories, Inc. (IDXX) gains after a Q2 beat, but the real story is in the details: recurring diagnostics growth, margin expansion, and a raised 2026 outlook. This deep-dive breaks down segment performance, pricing, instrument trends, and what the guidance implies for the stock.
IDEXX Laboratories, Inc. (IDXX) gains 3.7% after reporting earnings beats, as investors react positively to stronger-than-expected results and improved outlook.
Twist Bioscience Corporation (TWST) rose after a mixed quarter that featured an EPS miss but a revenue beat, continued sequential growth, and improving segment momentum. This deep dive examines the margin expansion, adjusted EBITDA breakeven path, and why investors focused on the bigger operating picture.
Twist Bioscience Corporation (TWST) rises after reporting earnings misses, with shares up 5.5% as investors react to the latest quarterly results.
Thermo Fisher Scientific Inc. (TMO) rises after a broad Q2 beat, margin expansion, and a full-year guidance raise. This deep-dive examines the company’s share-gain narrative, end-market strength, five-quarter EPS beat streak, and what the stronger organic growth outlook could mean for the stock.
Thermo Fisher Scientific Inc. (TMO) climbs 10.1% after reporting earnings beats, lifting investor sentiment as the company tops expectations and signals stronger-than-expected performance.
Revvity, Inc. (RVTY) rises after a clean Q1 earnings beat, but the real story is in the details: stronger-than-expected margins, steady organic growth, and a guidance reset tied to a strategic China exit rather than core business weakness. Here’s what the numbers and outlook really mean.
Revvity, Inc. (RVTY) rises 7.0% after reporting earnings beats, as investors react positively to stronger-than-expected results and improved outlook signals.
Twist Bioscience Corporation (TWST) drops despite revenue growth and raised guidance, as a wider-than-expected EPS loss overshadowed strong segment momentum, margin improvement, and continued sequential sales gains. This deep-dive breaks down the earnings miss, operating trends, and why investors focused on profitability over the top-line beat.
Twist Bioscience Corporation (TWST) drops 5.5% after reporting earnings misses, as investors react to weaker-than-expected results and reassess the stock's near-term outlook.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the GeneratorCancel anytime